NASDAQ:ONCT

Oncternal Therapeutics (ONCT) Earnings Date, Estimates & Call Transcripts

$0.32

+0.02 (+6.63%)

(As of 06/9/2023 ET)

Compare

Today's Range: $0.31
▼
$0.37
50-Day Range: $0.28
▼
$0.79
52-Week Range: $0.26
▼
$1.41

Volume: 489,575 shs
Average Volume: 198,767 shs
Market Capitalization: $18.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.77

Upcoming Earnings Date: Aug. 8Estimated
Actual EPS (Mar. 9): -$0.20 Beat By $0.02
Consensus EPS (Mar. 9): -$0.22
Last Year's Q1 EPS (3/10/2022): -$0.16

Earnings Per Share Revenue

ONCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Oncternal Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	3	($0.21)	($0.16)	($0.19)
Q2 2023	4	($0.17)	($0.15)	($0.16)
Q3 2023	4	($0.14)	($0.10)	($0.12)
Q4 2023	4	($0.12)	($0.11)	($0.12)
FY 2023	15	($0.64)	($0.52)	($0.58)

ONCT Earnings Date and Information

Oncternal Therapeutics last released its earnings results on March 9th, 2023. The reported ($0.20) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.02. The firm earned $0.17 million during the quarter, compared to the consensus estimate of $0.37 million. Oncternal Therapeutics has generated ($0.84) earnings per share over the last year (($0.84) diluted earnings per share). Earnings for Oncternal Therapeutics are expected to grow in the coming year, from ($0.60) to ($0.43) per share. Oncternal Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.

Oncternal Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/8/2023 (Estimated)
5/4/2023	Q1 2023	($0.21)	($0.20)	+$0.01	($0.20)	$0.20 million	$0.20 million
3/9/2023	Q4 2022	($0.22)	($0.20)	+$0.02	($0.20)	$0.37 million	$0.17 million
11/3/2022	Q3 2022	($0.24)	($0.21)	+$0.03	($0.21)	$0.43 million	$0.38 million
8/9/2022	Q2 2022	($0.23)	($0.23)		($0.23)	$0.57 million	$0.19 million
5/5/2022	Q1 2022	($0.19)	($0.20)	($0.01)	($0.20)	$0.70 million	$0.75 million
3/10/2022	Q4 2021	($0.25)	($0.16)	+$0.09	($0.16)	$2.03 million	$0.56 million

11/4/2021	9/30/2021	($0.16)	($0.19)	($0.03)	($0.19)	$1.30 million	$2.13 million
8/5/2021	6/30/2021	($0.14)	($0.16)	($0.02)	($0.16)	$1.09 million	$0.88 million
5/6/2021	3/31/2021	($0.10)	($0.12)	($0.02)	($0.12)	$1.11 million	$0.75 million
3/11/2021	12/31/2020	($0.18)	($0.09)	+$0.09	($0.09)	$0.59 million	$1.59 million
11/4/2020	9/30/2020	($0.30)	($0.22)	+$0.08	($0.22)	$0.62 million	$0.59 million
8/6/2020	Q2 2020		($0.34)	($0.34)	($0.34)		$0.62 million
5/7/2020	Q1 2020		($0.31)	($0.31)	($0.31)		$0.58 million
3/16/2020	Q4 2019		($0.27)	($0.27)	($0.27)		$0.74 million
11/7/2019	Q3 2019		($0.32)	($0.32)	($0.32)		$0.54 million
8/8/2019	Q2 2019	($1.68)	($1.27)	+$0.41	$0.84		$0.67 million
5/10/2019	Q1 2019		($1.68)	($1.68)	($1.68)
3/18/2019	Q4 2018		($1.61)	($1.61)	($1.61)
10/22/2018	Q3 2018	($2.10)	($2.73)	($0.63)	($2.73)
8/14/2018	Q2 2018	($3.01)	($3.01)		($3.01)
5/15/2018	Q1 2018	($3.01)	($4.34)	($1.33)	($4.34)
3/12/2018	Q4 2017	($2.73)	($3.01)	($0.28)	($3.01)
11/14/2017	Q3 2017	($1.96)	($3.71)	($1.75)	($3.71)
8/14/2017	Q2 2017		($2.80)	($2.80)	($2.80)
5/15/2017	Q1 2017		($2.73)	($2.73)	($2.73)
3/15/2017	Q4 2016	($3.99)	($3.08)	+$0.91	($3.08)
11/3/2016	Q3 2016	($3.50)	($3.50)		($3.50)
8/9/2016	Q2 2016	($3.50)	($2.80)	+$0.70	($2.80)
5/10/2016	Q1 2016	($2.80)	($3.50)	($0.70)	($7.70)
3/3/2016	Q4 2015	($7.00)	($4.20)	+$2.80	($5.60)
10/29/2015	Q3 2015	($3.50)	($2.80)	+$0.70	($2.80)
8/6/2015	Q2 2015	($2.80)	($2.10)	+$0.70	$19.59
5/8/2015	Q1 2015	($2.80)	($2.80)		($4.20)
3/4/2015	Q4 2014	($4.90)	($3.50)	+$1.40	$2.10
11/10/2014	Q3 2014	($7.00)	($4.20)	+$2.80	($4.20)
8/5/2014	Q2 2014	($7.70)	($10.50)	($2.80)	($10.50)
5/8/2014	Q1 2014	($8.40)	($9.80)	($1.40)	($9.80)
3/4/2014	Q4 2013	($9.10)	($8.40)	+$0.70	($8.40)
11/12/2013	Q3 2013	($14.70)	($9.80)	+$4.90	($9.80)
7/19/2013	Q2 2013	($14.70)	($14.00)	+$0.70	($14.00)

5/3/2013	Q1 2013	($14.70)	($14.00)	+$0.70	($14.00)

Oncternal Therapeutics Earnings - Frequently Asked Questions

When is Oncternal Therapeutics's earnings date?: Oncternal Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on ONCT's earnings history.
Did Oncternal Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Oncternal Therapeutics (NASDAQ:ONCT) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.02. Learn more on analysts' earnings estimate vs. ONCT's actual earnings.

How much revenue does Oncternal Therapeutics generate each year?: Oncternal Therapeutics (NASDAQ:ONCT) has a recorded annual revenue of $1.49 million.
How much profit does Oncternal Therapeutics generate each year?: Oncternal Therapeutics (NASDAQ:ONCT) has a recorded net income of -$44.17 million. ONCT has generated -$0.84 earnings per share over the last four quarters.
What is Oncternal Therapeutics's EPS forecast for next year?: Oncternal Therapeutics's earnings are expected to grow from ($0.60) per share to ($0.43) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:ONCT) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncternal Therapeutics (ONCT) Earnings Date, Estimates & Call Transcripts

ONCT Earnings Estimates and Actuals by Quarter

ONCT Estimated and Actual Revenue by Quarter

Oncternal Therapeutics Analyst Forecasts

ONCT Earnings Date and Information

Oncternal Therapeutics Earnings History by Quarter

Oncternal Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Oncternal Therapeutics (ONCT) Earnings Date, Estimates & Call Transcripts

Earnings Summary

ONCT Earnings Estimates and Actuals by Quarter

ONCT Estimated and Actual Revenue by Quarter

Oncternal Therapeutics Analyst Forecasts

ONCT Earnings Date and Information

Oncternal Therapeutics Earnings History by Quarter

Oncternal Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat